可能的迷幻治疗机制。
Possible psychedelic therapeutic mechanism.
机构信息
Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Pharmacology, University of Maryland School of Medicine, Baltimore, MD, USA.
出版信息
Science. 2023 Feb 17;379(6633):642-643. doi: 10.1126/science.adg2989. Epub 2023 Feb 16.
Abstract
Psychedelics act on intracellular serotonin receptors that are not accessible by serotonin alone.
摘要
迷幻剂作用于细胞内的血清素受体，而这些受体是单独的血清素无法到达的。
相似文献
1
Possible psychedelic therapeutic mechanism.可能的迷幻治疗机制。
Science. 2023 Feb 17;379(6633):642-643. doi: 10.1126/science.adg2989. Epub 2023 Feb 16.
2
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.迷幻剂通过激活细胞内 5-HT2A 受体来促进神经可塑性。
Science. 2023 Feb 17;379(6633):700-706. doi: 10.1126/science.adf0435. Epub 2023 Feb 16.
3
5-HT SNPs Alter the Pharmacological Signaling of Potentially Therapeutic Psychedelics.5-HTSNPs 改变潜在治疗性迷幻药的药理学信号传导。
ACS Chem Neurosci. 2022 Aug 17;13(16):2386-2398. doi: 10.1021/acschemneuro.1c00815. Epub 2022 Jul 27.
4
Psychedelics and schizophrenia.迷幻药与精神分裂症
Trends Neurosci. 2009 Apr;32(4):225-32. doi: 10.1016/j.tins.2008.12.005. Epub 2009 Mar 5.
5
Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.新型精神活性色胺与经典致幻剂的受体相互作用概况。
Eur Neuropsychopharmacol. 2016 Aug;26(8):1327-37. doi: 10.1016/j.euroneuro.2016.05.001. Epub 2016 May 20.
6
Psychedelics and Personality.迷幻剂与人格
ACS Chem Neurosci. 2018 Oct 17;9(10):2304-2306. doi: 10.1021/acschemneuro.8b00237. Epub 2018 Jun 4.
7
Psychedelic Psychiatry's Brave New World.迷幻精神病学的勇敢新世界。
Cell. 2020 Apr 2;181(1):24-28. doi: 10.1016/j.cell.2020.03.020.
8
Hallucinogens and Serotonin 5-HT Receptor-Mediated Signaling Pathways.致幻剂与血清素5-羟色胺受体介导的信号通路
Curr Top Behav Neurosci. 2018;36:45-73. doi: 10.1007/7854_2017_478.
9
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice.单次暴露于致幻剂后小鼠的表观基因组和突触可塑性的长期改变。
Cell Rep. 2021 Oct 19;37(3):109836. doi: 10.1016/j.celrep.2021.109836.
10
Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.定量磷酸化蛋白质组学揭示了致幻剂与非致幻剂激动剂对血清素2A受体Ser280位点磷酸化的偏向性作用。
Mol Cell Proteomics. 2014 May;13(5):1273-85. doi: 10.1074/mcp.M113.036558. Epub 2014 Mar 17.
引用本文的文献
1
From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence-Based Policy and Practice.从疗效到效果：评估迷幻药随机对照试验以获取可靠的循证政策与实践依据
Pharmacol Res Perspect. 2025 Apr;13(2):e70097. doi: 10.1002/prp2.70097.
2
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning-Based Advanced Perspectives.精神疾病中的迷幻药物：当前临床范围及基于深度学习的前沿观点
Adv Sci (Weinh). 2025 Apr;12(15):e2413786. doi: 10.1002/advs.202413786. Epub 2025 Mar 20.
3
Psychedelics and Pro-Social Behaviors: A Perspective on Autism Spectrum Disorders.迷幻剂与亲社会行为：关于自闭症谱系障碍的一种观点
ACS Pharmacol Transl Sci. 2025 Feb 10;8(3):903-906. doi: 10.1021/acsptsci.5c00034. eCollection 2025 Mar 14.
4
Art therapy and neuroscience: evidence, limits, and myths.艺术疗法与神经科学：证据、局限与误区
Front Psychol. 2024 Oct 2;15:1484481. doi: 10.3389/fpsyg.2024.1484481. eCollection 2024.
本文引用的文献
1
Preparing for the Bursting of the Psychedelic Hype Bubble.为迷幻药炒作泡沫的破裂做准备。
JAMA Psychiatry. 2022 Oct 1;79(10):943-944. doi: 10.1001/jamapsychiatry.2022.2546.
2
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial.裸盖菇素辅助心理治疗与安慰剂治疗酒精使用障碍成年患者后重度饮酒日的百分比：一项随机临床试验。
JAMA Psychiatry. 2022 Oct 1;79(10):953-962. doi: 10.1001/jamapsychiatry.2022.2096.
3
Exploratory study of the dose-related safety, tolerability, and efficacy of dimethyltryptamine (DMT) in healthy volunteers and major depressive disorder.探索性研究二甲基色胺（DMT）在健康志愿者和重度抑郁症患者中的剂量相关安全性、耐受性和疗效。
Neuropsychopharmacology. 2022 Sep;47(10):1854-1862. doi: 10.1038/s41386-022-01344-y. Epub 2022 Jun 3.
4
The Rapid Rise in Investment in Psychedelics-Cart Before the Horse.迷幻药投资的迅速增长——本末倒置。
JAMA Psychiatry. 2022 Mar 1;79(3):189-190. doi: 10.1001/jamapsychiatry.2021.3972.
5
Mechanisms of ketamine and its metabolites as antidepressants.氯胺酮及其代谢物作为抗抑郁药的作用机制。
Biochem Pharmacol. 2022 Mar;197:114892. doi: 10.1016/j.bcp.2021.114892. Epub 2021 Dec 27.
6
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.迷幻蘑菇辅助治疗对重度抑郁症的影响：一项随机临床试验。
JAMA Psychiatry. 2021 May 1;78(5):481-489. doi: 10.1001/jamapsychiatry.2020.3285.
7
Psychedelic Treatment for Trauma-Related Psychological and Cognitive Impairment Among US Special Operations Forces Veterans.美国特种作战部队退伍军人创伤相关心理和认知障碍的迷幻疗法
Chronic Stress (Thousand Oaks). 2020 Jul 8;4:2470547020939564. doi: 10.1177/2470547020939564. eCollection 2020 Jan-Dec.
8
Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.哺乳动物脑中 N,N-二甲基色胺（DMT）的生物合成和细胞外浓度。
Sci Rep. 2019 Jun 27;9(1):9333. doi: 10.1038/s41598-019-45812-w.
9
The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization.死藤水的治疗潜力：对各种文明病可能产生的影响。
Front Pharmacol. 2016 Mar 2;7:35. doi: 10.3389/fphar.2016.00035. eCollection 2016.
10
Psychedelics.迷幻剂
Pharmacol Rev. 2016 Apr;68(2):264-355. doi: 10.1124/pr.115.011478.
Zotero 插件